WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study (Q33438898)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study |
scientific article |
Statements
1 reference
WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study (English)
1 reference
Koussay Dellagi
1 reference
Afif Ben Salah
1 reference
Gloria Morizot
1 reference
Nathalie Ben Massoud
1 reference
Amor Zâatour
1 reference
Nissaf Ben Alaya
1 reference
Nabil Bel Haj Hamida
1 reference
Zaher El Ahmadi
1 reference
Matthew T Downs
1 reference
Philip L Smith
1 reference
Max Grögl
1 reference
5 May 2009
1 reference
1 reference
e432
1 reference
5 May 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference